|
LensAR Inc.
to Present Data from Laser Cataract Surgery Clinical
Trial at the Annual Meeting of the American Academy of
Ophthalmology
Winter Park, FL, October 13, 2009 – LensAR, Inc., a
leading developer of next generation laser technology
for cataract surgery and other ocular applications,
today announced that data from a recently completed
clinical trial of the LensAR Laser System will be
presented at the upcoming 2009 Joint Meeting of the
American Academy of Ophthalmology (AAO) and Pan-American
Academy of Ophthalmology (PAAO). The meeting will be
held October 23 – 27, 2009 in San Francisco, CA.
Clinical investigator Louis D. “Skip” Nichamin, M.D.,
medical director of the Laurel Eye Clinic Center in
Brookville, PA, will present LensAR’s clinical results
in a paper entitled, “Laser Capsulotomy with the LensAR
Laser System,” on Friday, October 23, 2009. The paper
will be presented during Section II: Cataract and
Refractive Surgery, “Refractive Surgery 2009: It’s Time
to Change,” at 9:08 a.m. Pacific in Moscone Center West,
Room 2014.
In addition to the data presentation, Ramon
Naranjo-Tackman, M.D., principal investigator for
LensAR’s clinical studies in Mexico, professor of
ophthalmology at the Universidad Nacional Autónoma de
México, and director of corneal service at the
Asociación Para Evitar la Ceguera en México, Hospital
Luis Sánchez Bulnes in Mexico City will give a guest
talk entitled, “Novel Uses of a Femtosecond Laser.” Dr.
Naranjo will present an overview of the early
experiences with capsulotomy and nuclear fragmentation
with the LensAR Laser System. His talk will take place
during Section XII: Pan-American Association of
Ophthalmology (PAAO) Symposium, scheduled for Saturday,
October 24, 2009 at 1:30 p.m. Pacific in Moscone Center
West, Room 2014.
For a video demonstration of LensAR’s Laser System,
please visit the company’s booth #547 at AAO-PAAO.
About LensAR, Inc.
LensAR, Inc. is a leading developer of next generation
laser technology for cataract surgery and other ocular
applications including presbyopia. The company has
recently completed a laser cataract surgery clinical
trial and filed a 510k application with the U.S. Food
and Drug Administration. LensAR expects to commercialize
its first systems in 2010. For more information on
LensAR and its laser technology, please visit our
website at
www.lensarinc.com.
Contact
Vida Communication (On behalf of LensAR)
Stephanie Diaz (investors)
415-675-7400
sdiaz @vidacommunication.com
Tim Brons (media)
415-675-7400
tbrons @vidacommunication.com
|
